IP Library Granted Patent US 8,236,549
Granted Patent B2
US 8,236,549 · App. 13/099,717 · Granted Aug 7, 2012

Patent

Assignee: Novozymes Biologicals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,236,549
App. No.
13/099,717
Granted
Aug 7, 2012
Kind
B2
Abstract

The present disclosure relates to a strain of Bacillus amyloliquefaciens bacteria that hyperproduces amylase enzyme and protease enzyme. The strain is also suitable for producing lipase for the degradation of oleaginous materials such as fats, greases and cooking oils. The strain also has excellent fungicidal and/or fungistatic qualities. The strain of the present disclosure and the enzymes produced thereby have a number of applications, including agricultural uses, laundry and dish detergents, drain cleaners and spot removers, and among other things, baking applications.

Claims (9)

1. A biologically pure culture of Bacillus amyloliquefaciens strain NRRL B-50350 having phage resistance.

2. A method of killing fungi comprising contacting fungi with an effective amount of Bacillus amyloliquefaciens strain of claim 1 .

3. A composition comprising the Bacillus amyloliquefaciens strain of claim 1 .

4. A composition in accordance with claim 3 further comprising one or more other microorganisms.

5. The composition of claim 3 , which further comprises a surfactant.

6. The composition of claim 5 , which further comprises one or more enzymes.

7. The composition of claim 6 , wherein the enzyme is selected from the group consisting of alpha-amylases, cellulases, lipases, mannanases, pectate lyases, peroxidases/oxidases, and proteases, or mixtures thereof.

8. The composition of claim 3 , which further comprises one or more ingredients selected from the group consisting of dispersants, stabilizers, anti-microbial agents, fragrances, dyes, and biocides.

9. The composition of claim 3 , wherein Bacillus amyloliquefaciens strain NRRL B-50350 is present in a concentration of from about 1×10 5 to 1×10 10 per ml.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2011
From: KANG, YAOWEI; SEMONES, SHAWN; SMITH, JESSICA; FRODYMA, MICHAEL
To: NOVOZYMES BIOLOGICALS, INC.
Reel/Frame 026300/0141 →
Continuity (2)
Provisional Application 61331203 · May 4, 2010
Related Publication 20110274673A1 · Nov 10, 2011